Iraq Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iraq Healthcare Wire.

Press releases published on June 10, 2026

Jun. 10, 2026

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

Indeterminate GlobeNewswire

Jun. 10, 2026

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

Indeterminate GlobeNewswire

Jun. 10, 2026

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

Indeterminate GlobeNewswire

Jun. 10, 2026

Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia

Indeterminate GlobeNewswire

Jun. 10, 2026

Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C

Indeterminate GlobeNewswire

Jun. 10, 2026

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Indeterminate GlobeNewswire

Jun. 10, 2026

Senior Dog Joint Supplements: What Veterinarians Look For

Indeterminate GlobeNewswire

Jun. 10, 2026

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Indeterminate GlobeNewswire

Jun. 10, 2026

Ligand Announces 2026 Investor Day in New York City

Indeterminate GlobeNewswire

Jun. 10, 2026

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

Indeterminate GlobeNewswire

Jun. 10, 2026

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

Indeterminate GlobeNewswire

Jun. 10, 2026

Fresh From the U.S., BrewDog Unleashes Iconic American Craft Beers Across the U.K.

Indeterminate GlobeNewswire

Jun. 10, 2026

BMGL to Effect Reverse Share Split on June 22, 2026

Indeterminate GlobeNewswire

Jun. 10, 2026

Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare

Indeterminate GlobeNewswire

Jun. 10, 2026

Tilray Medical Germany Launches ARX™, a New Premium Medical Cannabis Brand Cultivated in Germany

Indeterminate GlobeNewswire

Jun. 10, 2026

DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting

Indeterminate GlobeNewswire

Jun. 10, 2026

Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment

Indeterminate GlobeNewswire

Jun. 10, 2026

Italfarmaco annonce l’acceptation du dépôt et l’examen prioritaire par Santé Canada pour la présentation de drogue nouvelle du givinostat dans le traitement de la dystrophie musculaire de Duchenne

Indeterminate GlobeNewswire

Jun. 10, 2026

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate

Indeterminate GlobeNewswire

Jun. 10, 2026

CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome

Indeterminate GlobeNewswire